nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol valerate/Dienogest—Weight decreased—Lisinopril—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Estradiol valerate/Dienogest—Angioedema—Captopril—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Azathioprine—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Lisinopril—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal distension—Mycophenolate mofetil—systemic scleroderma	0.003	0.003	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Leflunomide—systemic scleroderma	0.003	0.003	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Estradiol valerate/Dienogest—Asthma—Mycophenolate mofetil—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Lisinopril—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Mycophenolic acid—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Leflunomide—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Captopril—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Leflunomide—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Pentoxifylline—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Leflunomide—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Mycophenolic acid—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Leflunomide—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Leflunomide—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Mometasone—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Captopril—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Leflunomide—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Prednisone—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal inflammation—Methotrexate—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Estradiol valerate/Dienogest—Pulmonary embolism—Methotrexate—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Mometasone—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Mometasone—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Leflunomide—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Mycophenolate mofetil—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Mycophenolic acid—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Pentoxifylline—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Estradiol valerate/Dienogest—Tension—Mycophenolic acid—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Lisinopril—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Estradiol valerate/Dienogest—Nervousness—Mycophenolic acid—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Pentoxifylline—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal infection—Methotrexate—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Estradiol valerate/Dienogest—Angioedema—Leflunomide—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Mometasone—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Leflunomide—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Estradiol valerate/Dienogest—Purpura—Prednisone—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Captopril—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Lisinopril—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Pentoxifylline—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Lisinopril—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Captopril—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Leflunomide—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Lisinopril—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Estradiol valerate/Dienogest—Tension—Lisinopril—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Mycophenolic acid—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Estradiol valerate/Dienogest—Nervousness—Lisinopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Pentoxifylline—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Lisinopril—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Pentoxifylline—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Pentoxifylline—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Pentoxifylline—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Captopril—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Mycophenolic acid—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Mometasone—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Estradiol valerate/Dienogest—Irritability—Prednisone—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Prednisone—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Leflunomide—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Mometasone—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Estradiol valerate/Dienogest—Angioedema—Lisinopril—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Captopril—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Mycophenolic acid—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Pentoxifylline—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Lisinopril—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Estradiol valerate/Dienogest—Visual disturbance—Methotrexate—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Estradiol valerate/Dienogest—Tension—Mycophenolate mofetil—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal distension—Prednisone—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Estradiol valerate/Dienogest—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Lisinopril—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.002	0.002	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.002	0.002	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Leflunomide—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Prednisone—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Mometasone—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Mometasone—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Captopril—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Mometasone—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Mometasone—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Leflunomide—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Lisinopril—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Captopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Leflunomide—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Estradiol valerate/Dienogest—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Azathioprine—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Estradiol valerate/Dienogest—Irritability—Methotrexate—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Mycophenolic acid—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Methotrexate—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Mometasone—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Prednisone—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Mycophenolic acid—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Prednisone—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Captopril—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Prednisone—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Leflunomide—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Leflunomide—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Prednisone—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Methotrexate—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Azathioprine—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Captopril—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Captopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Captopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Captopril—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Lisinopril—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Mycophenolate mofetil—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Estradiol valerate/Dienogest—Asthma—Methotrexate—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Lisinopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Leflunomide—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Methotrexate—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Lisinopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Captopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Leflunomide—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Leflunomide—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Prednisone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Azathioprine—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Mycophenolic acid—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Lisinopril—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Lisinopril—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Azathioprine—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Prednisone—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Azathioprine—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Azathioprine—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Methotrexate—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Azathioprine—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Leflunomide—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Prednisone—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Leflunomide—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Lisinopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Mycophenolic acid—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Prednisone—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Azathioprine—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Leflunomide—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Prednisone—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Lisinopril—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Mycophenolic acid—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Mycophenolic acid—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Leflunomide—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Methotrexate—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Estradiol valerate/Dienogest—Angioedema—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Methotrexate—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Mycophenolic acid—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Methotrexate—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Methotrexate—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Lisinopril—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Prednisone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Prednisone—systemic scleroderma	0.000992	0.000992	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000961	0.000961	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Methotrexate—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000941	0.000941	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Prednisone—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Prednisone—systemic scleroderma	0.000909	0.000909	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Prednisone—systemic scleroderma	0.000847	0.000847	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Methotrexate—systemic scleroderma	0.000846	0.000846	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Methotrexate—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Prednisone—systemic scleroderma	0.000825	0.000825	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Methotrexate—systemic scleroderma	0.000822	0.000822	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Prednisone—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Methotrexate—systemic scleroderma	0.000764	0.000764	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Prednisone—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Methotrexate—systemic scleroderma	0.00076	0.00076	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Prednisone—systemic scleroderma	0.000731	0.000731	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Prednisone—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Prednisone—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Prednisone—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Methotrexate—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Methotrexate—systemic scleroderma	0.00069	0.00069	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Prednisone—systemic scleroderma	0.000683	0.000683	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Methotrexate—systemic scleroderma	0.00068	0.00068	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Methotrexate—systemic scleroderma	0.000636	0.000636	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Methotrexate—systemic scleroderma	0.000611	0.000611	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Methotrexate—systemic scleroderma	0.000606	0.000606	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Methotrexate—systemic scleroderma	0.000606	0.000606	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Methotrexate—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Methotrexate—systemic scleroderma	0.000571	0.000571	CcSEcCtD
